Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cao

Showing results (351-360 of 388) with videos related to

Pageof 39
Sort By:
The Pharmacogenomics Journal|October 5, 2016
A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trialsA Sebio, S Stintzing, V Heinemann, et al.
The Pharmacogenomics Journal|October 28, 2015
Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancerY Sunakawa, S Cao, M D Berger, et al.
Journal of Medical Genetics|May 7, 2009
Association of chromosome 2q36.1-36.3 and autosomal dominant transmission in ankylosing spondylitis: results of genetic studies across generations of Han Chinese familiesJ Gu, J Huang, C Li, et al.
Polish Journal of Veterinary Sciences|October 2, 2020
Characterization of serum adiponectin and leptin in healthy perinatal dairy cows or cows with ketosis, and their effectson ketosis involved indicesL Shen, B Qian, J Xiao, et al.
The Pharmacogenomics Journal|June 1, 2016
Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancerY Sunakawa, S Cao, N B Volz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2015
Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trialsY Sunakawa, S Stintzing, S Cao, et al.
The Pharmacogenomics Journal|April 12, 2017
Prognostic impact of FOXF1 polymorphisms in gastric cancer patientsS Matsusaka, A H Wu, S Cao, et al.
The Pharmacogenomics Journal|April 1, 2015
Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapyS Cao, S Wang, H Ma, et al.
Allergy|March 6, 2023
Detection of gut and mucosal peptides through TOMAHAQ in healthy individualsE S Parsons, F Liu, A Kaushik, et al.
The Pharmacogenomics Journal|August 10, 2016
CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapyS Matsusaka, S Cao, D L Hanna, et al.
Pageof 39

Showing results (351-360 of 388) with videos related to

Sort By:
Pageof 39
The Pharmacogenomics Journal|October 5, 2016
A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trialsA Sebio, S Stintzing, V Heinemann, et al.
The Pharmacogenomics Journal|October 28, 2015
Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancerY Sunakawa, S Cao, M D Berger, et al.
Journal of Medical Genetics|May 7, 2009
Association of chromosome 2q36.1-36.3 and autosomal dominant transmission in ankylosing spondylitis: results of genetic studies across generations of Han Chinese familiesJ Gu, J Huang, C Li, et al.
Polish Journal of Veterinary Sciences|October 2, 2020
Characterization of serum adiponectin and leptin in healthy perinatal dairy cows or cows with ketosis, and their effectson ketosis involved indicesL Shen, B Qian, J Xiao, et al.
The Pharmacogenomics Journal|June 1, 2016
Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancerY Sunakawa, S Cao, N B Volz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2015
Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trialsY Sunakawa, S Stintzing, S Cao, et al.
The Pharmacogenomics Journal|April 12, 2017
Prognostic impact of FOXF1 polymorphisms in gastric cancer patientsS Matsusaka, A H Wu, S Cao, et al.
The Pharmacogenomics Journal|April 1, 2015
Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapyS Cao, S Wang, H Ma, et al.
Allergy|March 6, 2023
Detection of gut and mucosal peptides through TOMAHAQ in healthy individualsE S Parsons, F Liu, A Kaushik, et al.
The Pharmacogenomics Journal|August 10, 2016
CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapyS Matsusaka, S Cao, D L Hanna, et al.
Pageof 39